{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T13:05:09Z","timestamp":1765976709902,"version":"3.37.3"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T00:00:00Z","timestamp":1690502400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T00:00:00Z","timestamp":1690502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s11926-023-01113-w","type":"journal-article","created":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T10:02:38Z","timestamp":1690538558000},"page":"204-212","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Emerging Concepts in Precision Medicine in Axial Spondyloarthritis"],"prefix":"10.1007","volume":"25","author":[{"given":"Hugues","family":"Allard-Chamard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4521-2029","authenticated-orcid":false,"given":"Proton","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,28]]},"reference":[{"issue":"11","key":"1113_CR1","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1136\/ard.59.11.883","volume":"59","author":"MA Brown","year":"2000","unstructured":"Brown MA, Laval SH, Brophy S, Calin A. Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis. Ann Rheum Dis. 2000;59(11):883\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1113_CR2","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1080\/03009740701824613","volume":"37","author":"OB Pedersen","year":"2008","unstructured":"Pedersen OB, Svendsen AJ, Ejstrup L, Skytthe A, Harris JR, Junker P. Ankylosing spondylitis in Danish and Norwegian twins: occurrence and the relative importance of genetic vs. environmental effectors in disease causation. Scand J Rheumatol. 2008;37(2):120\u20136.","journal-title":"Scand J Rheumatol"},{"key":"1113_CR3","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.3389\/fimmu.2018.02933","volume":"9","author":"F Costantino","year":"2018","unstructured":"Costantino F, Breban M, Garchon HJ. Genetics and functional genomics of spondyloarthritis. Front Immunol. 2018;9:2933. Current overview of common and rare variants in SpA along with gene expression.","journal-title":"Front Immunol"},{"issue":"11","key":"1113_CR4","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1038\/ng.2007.17","volume":"39","author":"C Australo-Anglo-American Spondylitis","year":"2007","unstructured":"Wellcome Trust Case Control C, Australo-Anglo-American Spondylitis C, Burton PR, Clayton DG, Cardon LR, Craddock N, et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet. 2007;39(11):1329\u201337.","journal-title":"Nat Genet"},{"issue":"5","key":"1113_CR5","first-page":"308","volume":"17","author":"JA Osgood","year":"2018","unstructured":"Osgood JA, Knight JC. Translating GWAS in rheumatic disease: approaches to establishing mechanism and function for genetic associations with ankylosing spondylitis. Brief Funct Genomics. 2018;17(5):308\u201318. Highlights strategic approaches for follow-up functional studies after identification of disease-associated variants.","journal-title":"Brief Funct Genomics"},{"key":"1113_CR6","doi-asserted-by":"publisher","first-page":"671976","DOI":"10.3389\/fgene.2021.671976","volume":"12","author":"MS Chimenti","year":"2021","unstructured":"Chimenti MS, Perricone C, D\u2019Antonio A, Ferraioli M, Conigliaro P, Triggianese P, et al. Genetics, epigenetics, and gender impact in axial-spondyloarthritis susceptibility: an update on genetic polymorphisms and their sex related associations. Front Genet. 2021;12:671976. Evaluated genetic and epigenetic factors and their relationship with sex and bDMARDs response.","journal-title":"Front Genet"},{"issue":"8","key":"1113_CR7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11926-021-01027-5","volume":"23","author":"F Motta","year":"2021","unstructured":"Motta F, Pederzani A, Carena MC, Ceribelli A, Wordsworth PB, De Santis M, et al. MicroRNAs in axial spondylarthritis: an overview of the recent progresses in the field with a focus on ankylosing spondylitis and psoriatic arthritis. Curr Rheumatol Rep. 2021;23(8):59. Reviews recent discoveries related to the role of microRNAs in ankylosing spondylitis, focusing on their expression profiling.","journal-title":"Curr Rheumatol Rep"},{"key":"1113_CR8","doi-asserted-by":"crossref","unstructured":"Choi SW, O'Reilly PF. PRSice-2: polygenic risk score software for biobank-scale data. GigaScience. 2019;8(7).","DOI":"10.1093\/gigascience\/giz082"},{"issue":"3","key":"1113_CR9","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559\u201375.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"1113_CR10","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ajhg.2015.09.001","volume":"97","author":"BJ Vilhjalmsson","year":"2015","unstructured":"Vilhjalmsson BJ, Yang J, Finucane HK, Gusev A, Lindstrom S, Ripke S, et al. Modeling linkage disequilibrium increases accuracy of polygenic risk scores. Am J Hum Genet. 2015;97(4):576\u201392.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"1113_CR11","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1038\/s41467-019-09718-5","volume":"10","author":"T Ge","year":"2019","unstructured":"Ge T, Chen CY, Ni Y, Feng YA, Smoller JW. Polygenic prediction via Bayesian regression and continuous shrinkage priors. Nat Commun. 2019;10(1):1776.","journal-title":"Nat Commun"},{"issue":"1","key":"1113_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1\u201322.","journal-title":"J Stat Softw"},{"issue":"9","key":"1113_CR13","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1136\/annrheumdis-2020-219446","volume":"80","author":"Z Li","year":"2021","unstructured":"Li Z, Wu X, Leo PJ, De Guzman E, Akkoc N, Breban M, et al. Polygenic risk scores have high diagnostic capacity in ankylosing spondylitis. Ann Rheum Dis. 2021;80(9):1168\u201374. Most comprehensive polygenic risk scores (PRS) in multiple ethnicities in ankylosing spondylitis demonstrating a high diagnostic capacity.","journal-title":"Ann Rheum Dis"},{"issue":"7256","key":"1113_CR14","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/nature08185","volume":"460","author":"SM Purcell","year":"2009","unstructured":"International Schizophrenia C, Purcell SM, Wray NR, Stone JL, Visscher PM, O\u2019Donovan MC, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009;460(7256):748\u201352.","journal-title":"Nature"},{"issue":"1","key":"1113_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ajhg.2018.11.002","volume":"104","author":"N Mavaddat","year":"2019","unstructured":"Mavaddat N, Michailidou K, Dennis J, Lush M, Fachal L, Lee A, et al. Polygenic risk scores for prediction of breast cancer and breast cancer subtypes. Am J Hum Genet. 2019;104(1):21\u201334.","journal-title":"Am J Hum Genet"},{"key":"1113_CR16","doi-asserted-by":"publisher","first-page":"587876","DOI":"10.3389\/fgene.2020.587876","volume":"11","author":"Z Cui","year":"2020","unstructured":"Cui Z, Hou G, Meng X, Feng H, He B, Tian Y. Bidirectional causal associations between inflammatory bowel disease and ankylosing spondylitis: a two-sample Mendelian randomization analysis. Front Genet. 2020;11:587876. A well-executed two-sample Mendelian randomization (MR) to estimate the unconfounded causal associations between inflammatory bowel disease and ankylosing spondylitis.","journal-title":"Front Genet"},{"issue":"7","key":"1113_CR17","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37(7):658\u201365.","journal-title":"Genet Epidemiol"},{"issue":"2","key":"1113_CR18","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512\u201325.","journal-title":"Int J Epidemiol"},{"issue":"4","key":"1113_CR19","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304\u201314.","journal-title":"Genet Epidemiol"},{"issue":"6","key":"1113_CR20","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1093\/ije\/dyx102","volume":"46","author":"FP Hartwig","year":"2017","unstructured":"Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017;46(6):1985\u201398.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"1113_CR21","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1038\/s41467-019-09432-2","volume":"10","author":"G Qi","year":"2019","unstructured":"Qi G, Chatterjee N. Mendelian randomization analysis using mixture models for robust and efficient estimation of causal effects. Nat Commun. 2019;10(1):1941.","journal-title":"Nat Commun"},{"issue":"5","key":"1113_CR22","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693\u20138.","journal-title":"Nat Genet"},{"key":"1113_CR23","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1016\/j.csbj.2022.05.015","volume":"20","author":"FJ Boehm","year":"2022","unstructured":"Boehm FJ, Zhou X. Statistical methods for Mendelian randomization in genome-wide association studies: a review. Comput Struct Biotechnol J. 2022;20:2338\u201351. Reviewed recent development of Mendelian randomization methods in genome-wide association studies.","journal-title":"Comput Struct Biotechnol J"},{"issue":"5","key":"1113_CR24","first-page":"631","volume":"11","author":"MC Karreman","year":"2017","unstructured":"Karreman MC, Luime JJ, Hazes JMW, Weel A. The prevalence and incidence of axial and peripheral spondyloarthritis in inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis. 2017;11(5):631\u201342.","journal-title":"J Crohns Colitis"},{"key":"1113_CR25","doi-asserted-by":"publisher","first-page":"1095622","DOI":"10.3389\/fimmu.2022.1095622","volume":"13","author":"J Mei","year":"2022","unstructured":"Mei J, Wei P, Zhang L, Ding H, Zhang W, Tang Y, et al. Impact of ankylosing spondylitis on stroke limited to specific subtypes: evidence from Mendelian randomization study. Front Immunol. 2022;13:1095622.","journal-title":"Front Immunol"},{"key":"1113_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.951893","volume":"13","author":"S Chen","year":"2022","unstructured":"Chen S, Luo X, Zhao J, Liang Z, Gu J. Exploring the causality between ankylosing spondylitis and atrial fibrillation: a two-sample Mendelian randomization study. Front Genet. 2022;13: 951893.","journal-title":"Front Genet"},{"key":"1113_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.887326","volume":"13","author":"S Hu","year":"2022","unstructured":"Hu S, Xing H, Wang X, Zhang N, Xu Q. Causal relationships between total physical activity and ankylosing spondylitis: a Mendelian randomization study. Front Immunol. 2022;13: 887326.","journal-title":"Front Immunol"},{"issue":"1","key":"1113_CR28","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.humimm.2021.09.003","volume":"83","author":"J Jiang","year":"2022","unstructured":"Jiang J, Shao M, Wu X. Vitamin D and risk of ankylosing spondylitis: a two-sample mendelian randomization study. Hum Immunol. 2022;83(1):81\u20135.","journal-title":"Hum Immunol"},{"issue":"10","key":"1113_CR29","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1111\/1756-185X.14390","volume":"25","author":"X Sun","year":"2022","unstructured":"Sun X, Deng Y, Ma Y, Shao M, Ni M, Zhang T, et al. Common mineral nutrients in ankylosing spondylitis: a 2-sample Mendelian randomization study. Int J Rheum Dis. 2022;25(10):1129\u201336.","journal-title":"Int J Rheum Dis"},{"key":"1113_CR30","doi-asserted-by":"crossref","unstructured":"Bugaj B, Wielinska J, Swierkot J, Bogunia-Kubik K, Gorna K. VDR Polymorphic variants are related to improvements in CRP and disease activity in patients with axial spondyloarthritis that undergo anti-TNF treatment. Genes. 2022;13(10).","DOI":"10.3390\/genes13101873"},{"key":"1113_CR31","doi-asserted-by":"crossref","unstructured":"Bialy S, Iwaszko M, Swierkot J, Bugaj B, Kolossa K, Jeka S, et al. Th2 cytokines (interleukin-5 and -9) polymorphism affects the response to anti-TNF treatment in Polish patients with ankylosing spondylitis. International journal of molecular sciences. 2022;23(21).","DOI":"10.3390\/ijms232113177"},{"key":"1113_CR32","doi-asserted-by":"publisher","first-page":"3125922","DOI":"10.1155\/2021\/3125922","volume":"2021","author":"J Wielinska","year":"2021","unstructured":"Wielinska J, Swierkot J, Kolossa K, Bugaj B, Chaszczewska-Markowska M, Jeka S, et al. Polymorphisms within genes coding for IL-17A and F and their receptor as clinical hallmarks in ankylosing spondylitis. Mediators Inflamm. 2021;2021:3125922.","journal-title":"Mediators Inflamm"},{"key":"1113_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.631603","volume":"12","author":"M Iwaszko","year":"2021","unstructured":"Iwaszko M, Wielinska J, Swierkot J, Kolossa K, Sokolik R, Bugaj B, et al. IL-33 Gene polymorphisms as potential biomarkers of disease susceptibility and response to TNF inhibitors in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis patients. Front Immunol. 2021;12: 631603.","journal-title":"Front Immunol"},{"issue":"7","key":"1113_CR34","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.18594","volume":"4","author":"DK Menon","year":"2021","unstructured":"Menon DK, Rosand J. Finding a place for candidate gene studies in a genome-wide association study world. JAMA Netw Open. 2021;4(7): e2118594.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"1113_CR35","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/gene.2017.19","volume":"18","author":"XB Wang","year":"2017","unstructured":"Wang XB, Ellis JJ, Pennisi DJ, Song X, Batra J, Hollis K, et al. Transcriptome analysis of ankylosing spondylitis patients before and after TNF-alpha inhibitor therapy reveals the pathways affected. Genes Immun. 2017;18(3):184\u201390.","journal-title":"Genes Immun"},{"issue":"5","key":"1113_CR36","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00005-018-0513-y","volume":"66","author":"M Ciechomska","year":"2018","unstructured":"Ciechomska M, Bonek K, Merdas M, Zarecki P, Swierkot J, Gluszko P, et al. Changes in MiRNA-5196 expression as a potential biomarker of anti-TNF-alpha therapy in rheumatoid arthritis and ankylosing spondylitis patients. Arch Immunol Ther Exp. 2018;66(5):389\u201397.","journal-title":"Arch Immunol Ther Exp"},{"issue":"3","key":"1113_CR37","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/cz\/zoaa007","volume":"66","author":"WK Lim","year":"2020","unstructured":"Lim WK, Mathuru AS. Design, challenges, and the potential of transcriptomics to understand social behavior. Curr zool. 2020;66(3):321\u201330.","journal-title":"Curr zool"},{"issue":"8","key":"1113_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0071-8","volume":"50","author":"B Hwang","year":"2018","unstructured":"Hwang B, Lee JH, Bang D. Single-cell RNA sequencing technologies and bioinformatics pipelines. Exp Mol Med. 2018;50(8):1\u201314.","journal-title":"Exp Mol Med"},{"issue":"8","key":"1113_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111697","volume":"41","author":"JA Bibby","year":"2022","unstructured":"Bibby JA, Agarwal D, Freiwald T, Kunz N, Merle NS, West EE, et al. Systematic single-cell pathway analysis to characterize early T cell activation. Cell Rep. 2022;41(8): 111697.","journal-title":"Cell Rep"},{"issue":"1","key":"1113_CR40","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1038\/s42003-021-02931-3","volume":"4","author":"D Simone","year":"2021","unstructured":"Simone D, Penkava F, Ridley A, Sansom S, Al-Mossawi MH, Bowness P. Single cell analysis of spondyloarthritis regulatory T cells identifies distinct synovial gene expression patterns and clonal fates. Commun Biol. 2021;4(1):1395. Utilization of scRNA-Seq to perform the identification of novel Treg subset in AS that are able to suppress IL-12\/23 and TNF secretion by\u00a0monocytes through LAG-3.","journal-title":"Commun Biol"},{"key":"1113_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102901","volume":"133","author":"K Deschler","year":"2022","unstructured":"Deschler K, Rademacher J, Lacher SM, Huth A, Utzt M, Krebs S, et al. Antigen-specific immune reactions by expanded CD8(+) T cell clones from HLA-B*27-positive patients with spondyloarthritis. J Autoimmun. 2022;133: 102901.","journal-title":"J Autoimmun"},{"key":"1113_CR42","unstructured":"Yi K, Jo S, Song W, Lee HI, Kim HJ, Kang JH, et al. Single cell transcriptome and surface protein expression analysis identify OX40(+) GITR(+) pathogenic T helper 17 in ankylosing spondylitis. Arthritis Rheumatol. 2023. Identification of novel pathogenic T helper 17 in ankylosing spondylitis."},{"issue":"4","key":"1113_CR43","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/jcmm.17159","volume":"26","author":"C Ren","year":"2022","unstructured":"Ren C, Li M, Zheng Y, Cai B, Du W, Zhang H, et al. Single-cell RNA-seq reveals altered NK cell subsets and reduced levels of cytotoxic molecules in patients with ankylosing spondylitis. J Cell Mol Med. 2022;26(4):1071\u201382.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"1113_CR44","doi-asserted-by":"publisher","first-page":"19411","DOI":"10.1038\/s41598-020-76574-5","volume":"10","author":"H Yu","year":"2020","unstructured":"Yu H, Wu H, Zheng F, Zhu C, Yin L, Dai W, et al. Gene-regulatory network analysis of ankylosing spondylitis with a single-cell chromatin accessible assay. Sci Rep. 2020;10(1):19411.","journal-title":"Sci Rep"},{"key":"1113_CR45","doi-asserted-by":"publisher","first-page":"760381","DOI":"10.3389\/fimmu.2021.760381","volume":"12","author":"H Xu","year":"2021","unstructured":"Xu H, Yu H, Liu L, Wu H, Zhang C, Cai W, et al. Integrative single-cell RNA-seq and ATAC-seq analysis of peripheral mononuclear cells in patients with ankylosing spondylitis. Front Immun. 2021;12:760381. Integration of single-cell RNA-Seq and ATAC-Seq analysis to uncover epigenetic alteration in AS from PBMCs.","journal-title":"Front Immun"},{"issue":"1","key":"1113_CR46","doi-asserted-by":"publisher","first-page":"18975","DOI":"10.1038\/s41598-019-55441-y","volume":"9","author":"K Carlberg","year":"2019","unstructured":"Carlberg K, Korotkova M, Larsson L, Catrina AI, Stahl PL, Malmstrom V. Exploring inflammatory signatures in arthritic joint biopsies with spatial transcriptomics. Sci Rep. 2019;9(1):18975. First study that attempt at using spatial transcriptomics to understand the differential organization of immune cells from synovial biopsies of rheumatoid arthritis and spondyloarthritis patients.","journal-title":"Sci Rep"},{"issue":"1","key":"1113_CR47","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18(1):220.","journal-title":"Genome Biol"},{"issue":"9","key":"1113_CR48","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","volume":"50","author":"AV Khera","year":"2018","unstructured":"Khera AV, Chaffin M, Aragam KG, Haas ME, Roselli C, Choi SH, et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat Genet. 2018;50(9):1219\u201324.","journal-title":"Nat Genet"},{"issue":"10271","key":"1113_CR49","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0140-6736(20)32341-2","volume":"397","author":"F Humby","year":"2021","unstructured":"Humby F, Durez P, Buch MH, Lewis MJ, Rizvi H, Rivellese F, et al. Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial. Lancet. 2021;397(10271):305\u201317. Very illustrative biopsy-driven randomized controlled trial in rheumatoid arthritis that utilizes currently available precision medicine tools.","journal-title":"Lancet"},{"issue":"2","key":"1113_CR50","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1093\/rheumatology\/key069","volume":"58","author":"I Miyagawa","year":"2019","unstructured":"Miyagawa I, Nakayamada S, Nakano K, Kubo S, Iwata S, Miyazaki Y, et al. Precision medicine using different biological DMARDs based on characteristic phenotypes of peripheral T helper cells in psoriatic arthritis. Rheumatology. 2019;58(2):336\u201344.","journal-title":"Rheumatology"},{"key":"1113_CR51","doi-asserted-by":"crossref","unstructured":"Acosta-Herrera M, Gonzalez-Serna D, Martin J. The potential role of genomic medicine in the therapeutic management of rheumatoid arthritis. J Clin Med. 2019;8(6).","DOI":"10.3390\/jcm8060826"},{"issue":"9","key":"1113_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0222362","volume":"14","author":"JMB Rees","year":"2019","unstructured":"Rees JMB, Wood AM, Dudbridge F, Burgess S. Robust methods in Mendelian randomization via penalization of heterogeneous causal estimates. PLoS One. 2019;14(9): e0222362.","journal-title":"PLoS One"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-023-01113-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11926-023-01113-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-023-01113-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T03:38:42Z","timestamp":1694835522000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11926-023-01113-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,28]]},"references-count":52,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["1113"],"URL":"https:\/\/doi.org\/10.1007\/s11926-023-01113-w","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"type":"print","value":"1523-3774"},{"type":"electronic","value":"1534-6307"}],"subject":[],"published":{"date-parts":[[2023,7,28]]},"assertion":[{"value":"29 May 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"HAC has received consulting fees and has participated in the speaker bureau for AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Celltrion, Eli Lilly, Fresenius Kabi, GSK, Janssen, Novartis, Pfizer, and SOBI and has also received a research grants from Janssen, Eli Lilly, and Pfizer. QL has no conflict of interest to declare. PR has received consulting fees and has participated in the speaker bureau for Abbott, AbbVie, Amgen, Bristol-Myers Squibb, Celgene, Eli Lilly, Janssen, Novartis, and Pfizer, and has also received a research grants from Janssen and Novartis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}